Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) are lobular
intraepithelial neoplasms that are often grouped under the term lobular neoplasia (LN). The …

Lobular neoplasia (LN) is a histopathologic entity that encompasses both lobular carcinoma
in situ (LCIS) and atypical lobular hyperplasia (ALH). Management of LN is known to be …

Although pathologists have recognized the classic forms of lobular neoplasia for decades,
our understanding of this disease has changed markedly since its first description. The term …

Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …

The designation of noninvasive lobular neoplasia applies to atypical epithelial proliferations
composed of noncohesive cells secondary to loss or functional alteration of E‐cadherin …

Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is
divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS …

Purpose Controversy surrounds management of lobular neoplasia (LN),[atypical lobular
hyperplasia (ALH) or lobular carcinoma in situ (LCIS)], diagnosed on core needle biopsy …

BACKGROUND: No consensus exists on the need to excise breast lesions that yield classic
lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)(known together as …

Lobular neoplasia including lobular carcinoma in situ (LCIS) and atypical lobular
hyperplasia (ALH) may be identified in breast core needle biopsies as incidental findings or …

Atypical lobular hyperplasia and lobular carcinoma in situ are lesions that occur relatively
infrequently in the breast. They are also referred to under the umbrella term of 'lobular …